Bacchus sales face setback

Published: 2012-05-14 06:59:00

Updated: 2012-05-14 06:59:00

Dong-A Pharmaceutical enjoyed a spike in sales after Bacchus hit supermarkets’ shelves across Korea, posting record revenue of 46.7 billion won in the third quarter of last year due to the gradual fading of speculative demand.

But it didn’t take long for sales to dwindle. Dong-A saw Bacchus sa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK